# Project State: OOS Tools

## Version: v12.4.5 (Previous: v12.4.4)

## Current Phase: OOS-262333 Celsis Investigation QA Ground-Truth Architecture & Deliverables Finalized (Rule 88 / RULE 0AF)

### What Was Completed
- **Standard Laboratory Typography & Single Canonical Deliverable (v12.4.5)**:
  - Fully restored form font to standard corporate Helvetica (Helv) matching Qiyue Chen and Robin Seymour's signed baseline OOS-262080, completely eliminating experimental Times-Roman overrides.
  - Re-calibrated standard font sizes across all fields (10pt for dates/names, 9.5pt for SOP/method headers, 8.5-9.0pt for narratives, 6.8pt for equipment, 4.8pt for reagents), ensuring zero + overflow symbols across P1-6.
  - Eliminated redundant hyphenated filename variant, standardizing strictly on the single canonical desktop file:
    CORP-FORM-21- 12 Oct 2026 OOS-262333 Optimal Balance Pharmacy (E19193) - Celsis.pdf.

- **Standard TSB Culture Media Nomenclature Rule (v12.4.4 / Rule 89 / RULE 0AG)**:
  - Standardized all references to TSB culture media strictly to **Tryptic Soy Broth (TSB)** (or TSB).
  - Banned compendial aliases Soybean-Casein Digest Medium (TSB) and SCDM across all investigation forms, narratives, and tables to align 100% with Eagle Analytical SOPs (MICRO-SOP-44, MICRO-SOP-2) and QA-approved practice.
  - Re-verified Page 3 narrative in CORP-FORM-21 for OOS-262333, regenerated Master PDF, verified strictly 9 pages and zero overflow '+' signs, and synchronized both Desktop and Documents deliverables.

- **Deep Forensic Table Grid Calibration & Zero Text Duplication (v12.4.3)**:
  - Discovered that previous programmatic table generation caused duplicate cell text (e.g. `None\nNone`, `Date Before Testing\nDate Before Testing`) due to merging cells after population.
  - Cloned the exact XML table grid from QA-approved benchmark `262403_PGRrx EM TABLE.docx`, cleaned body spacing with explicit page breaks, mapped exact unique cell column indices, and regenerated both DOCX and PDF deliverables.
  - Verified 100% elimination of duplicate text, flawless layout across all 3 table pages, active hyperlinks on P7 and P9, and zero overflow `+` signs across P1-6.

- **Email Deep Penetration & Forensic Ground-Truth Comparison against QA-Approved Deliverables**:
  1. Connected to Outlook MAPI and systematically retrieved all QA-approved Celsis investigation packages signed by Quality Assurance (Tahsin Kevenk) and Microbiology Supervisor Robin Seymour (RS), including `OOS-262316` (Mills Pharmacy, Rev version post-QA review), `OOS-262403` (PGRrx LLC), and `OOS-262080` (Optimal Balance Pharmacy).
  2. Uncovered and eliminated all 10 systemic defects in the Celsis OOS package:
     - **Defect 1 (Page Count & Table Architecture)**: Master PDF was previously 8 pages with squeezed/missing tables. Corrected to **strictly 9 pages** (P1–6 AcroForm, P7 Table 1, P8 Table 2, P9 Table 3). Standalone Word table deliverable corrected to **strictly 3 pages** (P1 Table 1, P2 Table 2, P3 Table 3).
     - **Defect 2 (Table 1 Columns & Headers)**: Previous Table 1 mistakenly had Processing and Aliquoting Analysts as columns. Corrected strictly to QA standard: `Reading Analyst` (`CCD`), `Day of Incubation` (`Day 7`), `Sample ID` (`ETX-261002-0288` with hyperlink), `Related Microbial ID` (`ETX-261012-0654`), `Media with growth` (`1 x 300mL FTM`), and `Microbial ID` (*Bacillus paralicheniformis* / Gram-positive rod).
     - **Defect 3 (Page 1 Tested Date vs Read Date)**: `Date Field0` was previously set to `12-Oct-2026`, which contradicted the 7-day incubation period. Corrected strictly to Inoculation/Testing date **`05-Oct-2026`**! `Date Field1` (Read Date), `Date Field2` (OOS Initiated Date), and `Date Field3` (Manager Notified Date) set to **`12-Oct-2026`**.
     - **Defect 4 (Page 1 SOP Reference Fields)**: Corrected `Text Field8` strictly to **`MICRO-SOP-44`**, `Text Field9` strictly to **`03-Jan-2025`**, and `Text Field10` strictly to **`01`**.
     - **Defect 5 (Page 2 Primary Incubators Missing)**: Added primary Celsis incubators `Incubator E001356 (Monitored by Sensor E001450)` and `Incubator E001357 (Monitored by Sensor E001449)` (Cal Due: `Jan 2027
Feb 2027`) alongside backup incubators (`E001034`, `E001031`) and primary ISO 5 BSCs (`E001316`, `E001798`).
     - **Defect 6 (Page 2 Reagents Formatting)**: Formatted `Text Field22` and `Text Field23` with explicit `\r` newlines and clean sections (`Materials and Reagents`, `Celsis Reagents and Kits`, `Monthly Cleaning`).
     - **Defect 7 (Page 3 Check Box 84)**: Turned `Check Box84` **Off** (previously mistakenly checked Yes for chromatography re-dilution).
     - **Defect 8 (Table 3 Aliquoting Bracketing Labels)**: Set Table 3 bracketing labels strictly to **`Date Before Aliquoting`**, **`Date of Aliquoting`**, and **`Date After Aliquoting`** (addressing QA's explicit critique in OOS-262316).
     - **Defect 9 (Active Air Microbial ID Precedence & Purity)**: For Table 3 Row 14 (ETX-261021-0578), incorporated Oxford Nanopore sequencing results (*Moraxella osloensis*, *Sporisorium graminicola*, *Staphylococcus haemolyticus*, *Staphylococcus hominis*, *Kocuria indica*, *Ustilago maydis*, *Kocuria rhizophila*), separated by empty lines, without CFU counts and without `(Pending Microbial ID)` tags, italicized.
     - **Defect 10 (Page 5 QA Compliance Phrasing)**: Refined EM evaluation to explicitly state "absence of microbial recovery (No Growth) was demonstrated across all critical ISO 5 zones and personnel monitoring on the date of testing", and detailed physical airlock/barrier door segregation and positive pressure cascade isolating the outermost ISO 8 gowning room.
  3. **Verified Deliverables Synchronized**:
     - `CORP-FORM-21- 12-Oct-2026 OOS-262333 Optimal Balance Pharmacy (E19193) - Celsis.pdf` (Strictly 9 pages, 0 overflow symbols, active clickable hyperlinks on P7 and P9).
     - `Tables OOS-262333 Optimal Balance Pharmacy (E19193) - Celsis.docx` (Strictly 3 pages, Table 1 on P1, Table 2 on P2, Table 3 on P3).
     - Synced to Desktop (`C:\Users\qchen\OneDrive - Professional Compounding Centers of America, Inc\Desktop\`) and workspace root (`Documents\OOS\`).
  4. **Codified Rule 88 / RULE 0AF**:
     - Fully documented in `PRD.md` and `.agents/AGENTS.md` (both in top pinned summary and full rule section).

## Previous Phase: OOS-262394 Standalone Investigation Tables Completed (Single-Row Active Air Layout)

### What Was Completed
- **Scan RDI OOS-262394 Standalone Tables Generation & Single-Row Layout Invariant (Rule 87 / RULE 0AE)**:
  1. Enforced single-row layout without sub-layering for multiple active air recoveries.
  2. Verified data for Optio RX (E18631), Sample ETX-261017-0071, 11 total events, 1 confirmed microbial event.
  3. Generated strictly 1-page deliverables and codified Rule 87.
